Hydroxychloroquine in Rheumatology Patients
Protocol: STUDY00004484
Full Title
Incidence and severity of COVID-19 in Rheumatology patients taking Hydroxychloroquine
Description
This study enrolls adults who have a rheumatological condition and are followed by a rheumatologist. The purpose of this study is to compare the COVID-19 status of people who have been taking hydroxychloroquine to those who have not been taking it. Hydroxychloroquine is routinely prescribed for rheumatological conditions.

You will be surveyed by telephone once monthly to inquire about current medications, and any COVID-19 symptoms, testing, or treatment. We will call you once monthly for three months. We will not prescribe any new medications we will only monitor the medications you are taking.

Technical Description

(CSR#200596287778) There has been conflicting evidence to support the use of hydroxychloroquine for treatment of COVID-19 and what evidence is available is of poor quality. Additionally, there have been no studies to determine if the use of this medication is effective as prophylaxis against COVID-19. We hope to track patients already prescribed hydroxychloroquine for a rheumatological condition to determine if they develop COVID-19 with reduced frequency and/or reduced severity as compared to matched controls who are not prescribed hydroxychloroquine.

Keyword: COVID-19
Compensation: No
Eligibility
Adults ages 18+.
Patient follows with an outpatient Rheumatologist
Age Group: Adults
Principal Investigator: DAVID LLOYD
Contact(s)
DAVID LLOYD
drlloyd@buffalo.edu
+1 888-888-8888
Want to Learn More?
Let us know how the study team can reach you. If you do not hear back within 2 business days, reach out to the study team directly at the contact information above or email ctsiresearch@buffalo.edu and someone will assist you.